EC-Logo-2018_TM_CMYK.jpg
electroCore Engages FNK IR to Execute Expanded Investor Relations Program
September 24, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
June 03, 2024 08:30 ET | electroCore, Inc.
ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
March 05, 2024 16:05 ET | electroCore, Inc.
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
October 05, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Second Quarter 2023 Financial Results
August 09, 2023 16:05 ET | electroCore, Inc.
Record second quarter 2023 net sales of $3.6 million, an increase of approximately 65% over second quarter 2022 Company to host a conference call and webcast today, August 9, 2023 at 4:30 PM EDT ...
Clinical Trial
UM6P Ventures Invests in Infiuss Health to Improve Clinical Trial Participation and Health Equity in Africa
September 29, 2022 06:00 ET | UM6P Ventures (988809)
CASABLANCA, Morocco, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Today, UM6P Ventures announced its investment in Infiuss Health. The startup is developing a decentralized SaaS platform to power remote...